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Introduction
Globally, breast cancer is the most common cause of cancer-related death in women, with around 327,000 deaths each year. Around 1-35 million cases of breast cancer have been found each year and 4-4 million women are believed to be live with breast cancer worldwide. It has been speculated that in 2020, around 1-7 million women will be diagnosed with breast cancer, which is an increased of about 26% in the developing world from current levels (Wong et al., 2009 ). In India, almost 100,000 women are diagnosed every year with breast cancer, and a rise to 131 000 cases is predicted by 2020 (Agarwal et al., 2008; Mangtani et al., 2010) . And in North-East India breast cancer has always been a hotspot in comparison to rest part of the India because of genotoxic stress from tobacco exposure (Sunita et al., 2010) .
Several environmental risk factors that may contribute to or hasten the development of breast cancer have been identified, including mainly lifestyle and reproductive factors. The factor with the strongest breast cancer risk association is a family history of breast and/or ovarian cancer, the associated risk being even higher for family history of early-onset disease (< age 40) (Datta et al., 2009) . Genetic susceptibility to breast cancer is triggered in several ways; the best understood causal mechanism being due to germline mutations in tumor suppressor genes. Together, mutations in BRCA1 and BRCA2 genes account for the great majority of families with hereditary susceptibility to breast and ovarian cancer (Ford et al., 1998) .
Among breast cancer patients, up to 5%~10% are considered directly relating to the inheritance of mutation in BRCA 1 (MIM 113705,Genbank accession no. U14680) and BRCA2 (MIM 600185, Gene bank accession no. U43746), which accounts for most of the hereditary breast cancers (Claus et al., 1994) . Moreover, women carrying these mutations have 60%~80% prone to breast cancer and ovarian cancer (Wooster et al., 2003) . The BRCAI gene is located on long arms of chromosomes 17 and it encodes a protein of 1863 amino acids (Hall et al., 1990) . The protein physically associates with p53 and involved in homologous recombination (HR) and double-strand break repair in response to DNA damage (Greenberg 2008; Zhang et al., 2010) . Miki et al. describes that BRCAI is a strong candidate for the breast and ovary cancer (Miki et al., 1994) . The spectrum of BRCAI mutations has been characterized in different populations worldwide, with significant variation of the relative contribution of these genes to hereditary cancer between populations (Brozek et al., 2011) . However, the contribution of mutations in these two genes to breast cancer patients in the Indian population remains relatively unexplored apart from a few small studies (Saxena et al., 2006) . Thus, the screening of prevalence of mutations in BRCAI gene will serve as a molecular predictor for women with breast cancer along with ovarian cancer in North-East Indian population. Accumulation of various environment and genetic factors during lifespan of an individual can combine to form pathogenesis in breast cancer. Direct analysis of the tumor genome can reveal the genomic events accumulated during tumor progression. Hence, we investigated genomic alterations in thirty two breast cancer participants of North-East India with consideration to the exon 2 and 'Biotechnology Department. Assam University. 'Cachar Cancer Hospital and Research Centre. Silchar Jagadish Hansa et al exon 11 of BRCAl gene. The main focus behind the study is to estimates genetic influence of BRCAl in Northeastern population, which would be able to make better decision about medical and surgical preventive options.
Materials and Methods
Case selection
Thirty-two breast cancer tissues of female patients' (aged 29-73 years) were randomly chosen and used in the study from the CCHRC in 2009-2011 along with their consent letter. To examine the population frequency of any sequence variants identified in the patients, a series of age matched control samples were also collected from women. The genetic background of the population studied was unknown prior to study. Patients' selection was mainly based on following observation: 1) Younger women effected from breast cancer (<40). 2) Previous personal history of a patient related to breast cancer. 3) Family history of the breast cancer patients.
Methods
Fresh cancerous and matched normal (adjacent nonneoplastic) tissue's specimen as well as blood samples were collected into EDTA vials from thirty two randomly selected patients from Cachar Cancer Hospital and Research Centre (CCHRC). The study was carried out after taking written informed consent from the participant. The extraction of DNA from tissue and blood were done by phenol/chloroform method (Ghosh et al., 2011) . The supernatant containing total genomic DNA was aliquot and stored at -20°C. The isolated DNA was checked by the spectrophotometer and gel electrophoresis; by the help of its purity and quantity', the DNA was processes for the PCR amplification. The quantity of DNA used for PCR reaction was about 50-100 ng. The coding regions of BRCAl gene were screened for DNA sequence variants by PCR techniques using exon specific primers (Table 1) . It was performed and monitored in Veriti PCR machine (Applied Biosystems Inc., CA, USA) for 30 cycles (Table  2 ). The reaction's mixture contained total volume of 30//I. Then PCR products were eluted from the agarose gel by the help of QIAkit® (Cat. No. 28704, USA) and processed for bidirectional Sanger sequencing at Bose Institute, India
Bio-informatics Tools
Raw nucleotide sequences from the sequencing results were processed through Sequence Scanner vl .0 (Applied Biosystem). The exported sequences were analyzed by using BLASTN software at NCBI site. According to the highest similarities, we depict the peak through the Chromas 2 software, and show the variations among sequences in figure panel.
Table 3. BRCAl Deleterious Mutation in North-Eastern
Results
This is the first report in BRCAI mutations from breast cancer patients of North-East India. We have designed our experiment to perceive the spectrum of mutation in breast cancer patients as well as the age matched controls. In the present investigation, we had selected three patterns of observation, age, personal history and family history of the patient.
In consideration to the studied data, the most common age group consisting of women 46-57 years around 90.62%, with the mean age of onset for 32 women diagnosis with breast cancer surveyed during 2009-2011 was 48 years (Table 2 ). Approximately 9.37% of cases were diagnosed under the age of 40 years. In relation to the age and breast cancer, the percentage of breast cancer in the younger women is quite high in this region. 6.25% patients have the personal history of breast cancer, and they found out with the breast cancer disease ( Table 2) . Reminiscent of this, the personal history of a patient with breast cancer in one breast or related cancer in other parts of the body has a 3 to 4 fold increased risk of developing a new cancer in other breast or in another part of the same breast. From the present exploration of mutational research study, we have found that 12.5 \% of the patients, whose have breast cancer in first-degree relative (Table 2) .
By the help of three sets of primer, we amplified the particular regions of the BRCAl gene and screened for alterations of the particular position of l85DelAG, IOI4DelGT and 3889DelAG of exon 2, I la and I Id respectively (Figure 1 ). To facilitate the objective of this study, we used the PCR technique and DNA sequencing technology for screening of all patients for the particular region of mutation with this population. The mutation rate is high, more than 40% were found to be positive with :htip:lldx.doi.orgll0.7314IAPJCP.20l2.}3.ll.587l ISSDelAG, lONDelGT and 3889DelAG BRCAI Mutations in Breast Cancer Patients from North-East India al., 2004) . Our study comprises a lower mean value of age, which is revealed that the disease occurs a decade earlier, as compared to western countries (Sandhu et al., 2010) . The probable reason for the early onset of this dreaded disease in the younger women may be due to personal history with a breast cancer/ovary cancer (Liang et al., 2011) , family history of breast cancer, particularly in a mother, sister and daughter (Metcalfe et al., 2010) , history of radiation therapy to the chest before age 40. (Narod, 201I) The aim of the mutational research analysis was to study the incidences and distribution of mutations in North-Eastem region of India concerning the other factors relating for breast cancer. For the diagnosis of breast carcinoma, FTsIAC technique was used as it is a useful diagnostic tool because of its cost efficient and rapidness (Sandhu et al., 2010) . Three deleterious nonsense mutations resulting in a premature termination codon were identified in BRCAI: 185DelAG in exon 2; ]014DelGT and 3889DelAG in exon 11, rather absent in the observed control group. Nonsense mutations of these three specific mutations are very detrimental lo the protein; it can render the resulting protein non-functional due to formation of stop codon at the early stage. Unexpectedly, we have gathered an ISSDelAG in North-East Indian Hindu patient residing in Cachar district who claimed to have family history but not to Jewish ancestry (Figur? 1 b) . In India, 185DelAG has been reported in all populations studied (Kumar et al., 2002; Hedau et al., 2004; Valarmathi et al., 2004; Saxena et al., 2005) . Similarly, Lakhotia et al. found the same mutation by the help of conformation sensitive gel electrophoresis in four Indian breast cancer families (Lakhotia et al., 2010) . Worldwide population studies have revealed that the ISSDelAG mutation predates the severance of Sephardi and Ashkenazi Jewish populations and is probably 2000 years old (Bar-Sade et al., 1998) . BRCAI 1014DelGT was detected in two Muslim index cases of without any family history from Karimganj District, but both have the personal history of ovary cancer ( Figure Id) . Interestingly, the same mutation was reported in a heterogeneous Pakistani population of Muslim religious (BIC-NHGRI).The specific position of 1014DelGT comes under the part of a DNA binding region where other tumor suppressor proteins could not bind and unable to form complex protein for the downstream act of protein. These observations suggest that 1014DelGT might be a common mutation in the Muslim community and might have migrated to the Indian population through a pool of Muslim immigrants (Liede et al., 2009 ). In North-Eastern region, the mutation of 3889DelAG is higher than the rest of the mutation found (Figure 1 f) , out of nine, three have the family history and found scattered in studied population; it also found in various populations of the world (Thirthagiri et al., 2008; Farooq et al., 2011) . The location of 3889AG is towards the C terminus of BRCAI, within the transcriptional activation domain, a region as well reported to interact with the BRCA2 protein, which plays an important role in double stranded break (DSB) repair (Roy et al., 2012) . Nevertheless, the number of mutations identified in the studied North-East Indian population is higher; it may be due to the selected these three variations of the BRC A1 after screening. And from that, most of the mutation occurrences were from the exon 11, out of the 32 patients 12 have the mutation which was around 37.5% and in exon 2, the incidences of mutations were quite low (around 3.12%) to the other part of world ethnicity. In commencing exon 11, we have screened two parts of the partial sequence; those were exon 11 a and 11 d of 192 and 194 bp product of amplicon respectively (Table 1 ). The mutation rate of lOHDelAG and 3889DelAG was 09.37% and 28.12% correspondingly (Table 3) .
DOI
In summary, we found two mutations of two base pair deletion in exon 11 among 12 patients (1014 Del GT {3 Patients} and 3889DelAG {9 patients}) which results in protein truncation of BRCAI protein by forming stop codons at 303 and 1265 position of amino acid respectively and one mutation of two base pair deletion at e.\on 2 (ISSDelAG) results in a stop codon at 39 position of amino acid in BRCA1 protein. Cachar Cancer Hospital and Research Centre support the observations, evaluations and findings of the research study undertaken among breast cancer patients from the North-East India.
Discussion
In the last few years many studies have focused in screening of mutations in breast/ovarian cancer. In this study majority of patients were at the fourth stage and large percentage of the patients who come to the CCHRC seeking care owing to their nominal incomes. Generally, breast cancer can occur at any age but younger women are less susceptible to ward's breast cancer (Mathew et
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Jagadish Hansa et at candidate who comes under the three patterns of the study. This significant proportion of mutation from BRCAl suggests one of the several possibilities for genetic predisposition in the North-East Indian population.
The results of this primary study put forward that the mutational spectrum in exons 2 and exon 11 of BRCAl gene in this population may be at variance from what has been observed in other Indian populations. Further studies or mutational screening of the whole BRCA1 gene from different geographical regions of India will help in identifying the mutations may provide the knowledge of biological properties of the protein corresponding to polymorphism. Through this aspect of proper counselling, patients and pre-symptomatic mutations carriers' studies would be able to make better decision about medical and surgical preventive options.
Introduction
World-wide epidemiological studies have shown that cancer of the uterine cervix is the second most common malignant disease in women (Ogunmodede et al. 2007 ). Virtually every cervical cancer (99.7%) is HPV-positive, indicating that the presence of HPV is an obligatory element in the development of cervical cancer . Specific anogenital types of human papillomavirus (HPV) cause the initiating infection that leads to cervical cancer. More than 100 HPV types are known, of which at least 70 infect the anogenital tract. Knowledge of HPV status is becoming increasingly important as a triage screen after detection of atypical cells of undetermined significance (Bollmann et al., 2003) and as a primary screen for cervical cancer detection (Cuzick etal.,2000) .
HPV typing has an important prognostic or therapeutic value, as it can distinguish between HPV types of high and low oncogenic risks. Identification of high-risk HPV genotypes may permit selection of those patients who are at increased risk for disease and may therefore provide additional clinical value. An important requirement for this approach is that HPV testing and identification of high-risk HPV types should be highly sensitive and specific (Speich et al., 2004) . The types associated with diseases of the anogenital tract can be classified on the basis of phylogenetic relationship (Zur Hausen, 1996) and of associated frequencies with benign or malignant cervical lesions as high-risk types and low risk types . The most common HR types are HPV-16,-18,-31.-33, and -45 (Bosch et al., 1995; Nobbenhuis, 1999) . HPV genome can be divided into three different regions including early, late and long control regions (Moosavi et al., 2008) . Early region proteins are classified into two groups: El, E2, E3 and E4 proteins, and E5, E6 and E7 oncoproteins (Dyson, et al., 1989) . E5 oncoproteins stimulate the growth of epithelial cells and in many cancers, lead to increased cellular mitosis and consequently cause papilloma lesions (Prayitino, 20.06) . E6 oncoprotein has been implicated in causing chromosomal abnormalities and progression of cells to neoplasia. E6 is also responsible for causing damage to P53 (Pei, 1996) . E7 oncoprotein binds to Rb gene products and other similar proteins thereby inactivating them (Kim, 2(K) I).
The detection and type-specific classification of HPV infection by in vitro viral culture is not possible and serological tests are still ineffective. Direct hybridization based assays, such as Southern blotting and in situ hybridization have been described, but lack sensitivity and specificity (Szuhai, 2001) . It has been reported in many studies that target DNA amplification may offer more specificity and sensitivity in detecting HPV infection (Malloy, 2000) . In this study we have compared the diagnostic efficacy of PCR based techniques over cytological examination in the direct detection of HPV infection involving HPV 16 and HPV 18 as well as evaluated the relevance as a screening technique. 
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Materials and Methods
Samples
Samples were collected from fifty patients attending Cachar Cancer Hospital, Silchar, Silchar Medical College and Hospital, Silchar and different infertility clinics of Southern Assam, who had positive pap smear during May-November, 2010. Considering the short duration of the study, no follow-up was done as part of this study in patients who were found positive for HPV infection by cytological/PCR methods except being referred for further appropriate clinical consultation. Samples were collected with informed consent of subjects.
Cytological Methods
Smears were collected with Ayer's spatula and immediately fixed in absolute alcohol for minimum 6 hours. The smears were then washed with distilled water and dipped in hemat'oxylene for 7 to 10 minutes. These were subsequently washed in running tap water and dipped in 1% acid alcohol for decolourization, and repeated twice. After third washing, the smears were dipped in 50% alcohol and transferred to O.G 6 solution and kept for 2 to 3 minutes. These were then dipped in absolute alcohol and transferred to EA 50 solution and kept for 20 to 30 minutes. After final dipping in absolute alcohol, the smears were cleared with xylene and mounted for viewing under optical microscope.
DNA extraction
Cervical samples were taken with sterilized swab and put in sterilized collection tubes.The samples were stored at 04°C until DNA isolation.To isolate DNA, sample was taken and mixed with 500/^Lof TES buffer.Then 30/50;/L of 10% SDS and 2/5/<L of proteinase K was added to it and kept in a water bath for iHr at 57°C. Equal amount of phenol chloroform isoamylalcohol (25:24:1) was added and centrifuged at 12000rpm for 8mins. The supernatant was taken and equal amount of chloroform isoamylalcohol (24:1) was added and further centrifuged. The supernatant was again taken and twice the amount of absolute alcohol was added and kept in refrigerator for some time. The refrigerated supernatant was next centrifuged, alcohol discarded and washed with 200 -500 ;/l of 70% alcohol and kept for drying. After that 20 -50//L nuclease free water was added and left overnight. Isolated DNA was checked under agarose gel electrophoresis in a 1 % gel and observed in UV transilluminator for purity. FAST PCR amplification using AmpliTaq GOLD (2X):The following PCR steps were employed for FAST PCR (AmpliGOLD-Applied Biosystem) of the total volume of 20 ul.
Step Reactivation PCR (30 cycle) of Enzyme
Final step
Hold Denatu Anne Exte RAM Hold ration aling nsion Temp 95<' C 95"C 58 68"C 72"C 4°C Time lOmin 3 sec 3 sec 3 sec 15 sec 15sec
Total Time taken-Reactivation of Enzyme (10 min) + PCR for 30 cycles |3-H3+3=9 second X30=270 sec (4!/^ min)l + 30 sec QA min)= 15 min
Results and Discussion
In our study, samples were collected from fifty patients as described previously. To avoid false positive results, and more confirmation of HPV genotype, we use this new technique to detect HPV. The mean age of patients was forty five years (ranging from twenty to seventy) and the highest number of HPV positive cases belonged to patients aged forty to fifty years. The presence of amplifiable DNA, using primers for HPV 16 and 18 was confirmed in twenty four (24%) out of the fifty samples. Out of the twelve positive cases HPV type 18 was present in ten cases and HPV type 16 was present in two cases. The PCR was carried out using Fast-PCR method by Applied biosystem reagents (details in Materials and Methods) within in 15 min. with the primers specific to the subtype 16 and 18 and the product sizes were 246 bp (product from L1 region base 379 to 624 with forward -reverse primers) and 162 bp (product from El region base 1448 to base 1609 with forward -reverse primers) respectively, depicted in Figure  1 .
Our result showed that the occurrence of affected percentage of HPV type 18 is high in comparison to the HPV type 16 in our geographical region. In nineteen cases (76%), it was not possible to identify the virus genotype which we attributed to possibly false positive results of cytological tests or may be due to the presence of other genotypes. Molecular (PCR) tests may accurately identify different types of HPV (of low and high cancer risks) in cells from cytological screening of cervical lesions and, due to their high sensitivities, have been the focus of attention of many studies (Bauer et al., 1992) . The purpose of our study was to detect the HPV 16 and 18 strains by PCR technique with the help of two pairs of primers. The advantage of this PCR based assay, unlike the other currently available assays, is that it is able to report the actual genotype of the HPV detected, rather than issue a broad based ambiguous diagnosis of HPV infection. In the present study, cervical smears were simultaneously subjected to cytological examination as well as PCR technique of detection. The traditional way of classifying tumors is by histopathology. The ability to analyze change in the levels of the transcripts and/or protein products for literally thousands of genes promises interesting possibilities as a research tool for understanding the underlying molecular mechanisms, but also for automated tissue diagnosis (Drain et al., 2002; Oh et al., 2009 ). HPVs frequently infect humans. They are classified into categories of low risk types responsible for the most common sexually transmitted viral infections and high risk types which are crucial etiological factors in cervical cancer development (McFadden and Schumann, 2001 ). The direct detection of HPV in cervical specimens may offer an alternative (?) or complement to population-based cytological screening. Recent studies have demonstrated that HPV test results are more sensitive (although they are less specific) than Pap smears in detecting high-grade dysplasia in older women (Schiffman et al., 2000; Wright et al., 2000) . In most scenarios women with positive HPV tests still have Pap tests or a diagnostic procedure to provide cytological . or histological confirmation of their disease.
We conclude that PCR based diagnosis may be a more specific test for detection of HPV subtypes. Contrary to many studies, it seems that PCR based diagnosis of HPV may not be ideal as a screening test in comparison to conventional pap smear studies, although it may be complementary. However, the use of PCR technique, covering all strains, may be a more sensitive diagnostic procedure that can help to differentiate between suspicious lesions and confirmed HPV infection at risk of subsequent malignancy. We suggest that further studies, covering larger study groups in other geographical locations, are required to draw a firm conclusion as to the diagnostic significance/advantage of PCR techniques over conventional methods. Email: drsankarghoshS>gmall.com E ach year 10.9 million people suffer from breast cancer worldwide that result in 6.7 million deaths from the disease. In India, one In 17 women Is suffering from breast cancer during their lifetime. The breast cancer susceptibility genes, BRCA1 and BRCA2 are thought to account for the majority of breast/ovarian cancer families. Here, we examined the partial coding sequence of the BRCA1 gene taking exon 2, 11 and 20 as these exons are mostly affected, globally reported from breast cancer Information core databases. Genomic DNA was isolated from 32 patients'tissue with matched blood diagnosed by Fine Needle Aspiration Cytology (FNAC) and biopsy. With the help of 3 sets of BRCA1 primers, mutation analysis was carried out using polymerase chain reaction (PCR) followed by DNA sequencing. We found two mutations of two base pair deletion In exon 11 among 12 patients (1014 delGT {3 Patients} and 3889 delAG {9 patients)) which results In protein truncation of BfiCAl protein by forming stop codons at 303 and 1265 position of amino acid respectively and one mutation of two base pair deletion at exon 2 (185delAG) results a stop codon at 39 amino acid of BRCAl protein which has been described In Ashkenazi Jewish families. Northeast Indian populations have not been extensively studied^ for prevalence and spectrum of mutations in cancerous patient. This sequenced based analysis will give ideas to understand the early onset of familial breast cancer. Of the diseases, cancer and thyroid dysfunction (hypothyroidism) is one of the major health issues which may occur due to genetic polymorphism apart from environmental stress. Detection of mutations in TPO , BRCA 1 gene and D-loop region of mtDNA In case of thyroid dysfunction, breast & oral cancer respectively and developing an effective technique called COLD-PCR (Nature Medicine;14;2009), for the enrichment and detection of mutation without sequencing. PCR amplification was done using respective primers for the desired gene followed fay direct sequencing of the amplified products for detecting mutations In different samples. For large scale of samples mutation detection was done using COLD-PCR technique, for which primers were designed In such a way that will amplify only the mutation point In the gene which gave product size lOObp in all three cases.The COLD-PCR was performed with our clinical samples (mutated DNA) with the normal samples (wild type DNA) for further validation of the Indels. In TPO gene insertion mutation was found in exon 8 (7bp ins at 1183_1190 Ins GTGCATG and 4bp Ins 1203_1207 InsTGGT) and deletion mutation in exon 9 (Ibp del at 1562 i.e. 1562delA and 6bp del at 1583 i.e. 1583_1S89 del CATGCC) respectively. In case of BftCAl gene three mutations were found, out of which two of them were mutations of two base pair deletion in exon 11 (1014 delGT and 3889 delAG ) and one was two base pair deletion at exon 2 (185delAG). In D-loop region mutations at nucleotide position 146 (TSC) and 152(CiT) occurred simultaneously in all the cases which were hotspot mutation in oral cancer and were detected using COLD-PCR in large number of samples. Thus, COLD-PCR is a reliable technique for detection of mutation In different genes without doing direct sequencing and therefore, reducing time and expenses for molecular diagnosis of diseases like thyroid dysfunction, detection of somatic mutations in cancer in diverse clinical samples. MDPO Induced celt death In T24 human bladder cancer cells In a time and dose-dependent manner. Intranucleosomal cleavages and PI staining confirmed that the cell death Initiated by MDPD was due to apoptosls. Further, regulatory on G0/G1 arrest was pnsved by (low cytometric studios. RT-PCR and lmmurx)blottlr>g studies showed ttie level of p53 was increased upon treatment with MDPO. Simultaneously the level of cyciin D and cdK2 were decreased. MDPD Induced Ijax up-regulatlon, an apoplotlc regulatory matVer accompanied by an apparent down-regulation of Bc:t-2 at genetic level. A good comelallon tjetween loss o( mitochondrial rrMjmtjrane potential and cytochrome c release was observed Indicating the participation ot mltochondrta-related mechanism. Tneatmei« of T24 colls wrlth MDPD also Induced the activation ot initiator caspase-9 protein levels whlt:h led to induction of apoptosls. In addition, MDPO also pTOmoted caspase-3 awivlty after exposure (or 6, 12 and 2A h. validating the apoptotic cell death. Furthermore, ttie MDPD-lndut»d apoptx>sls on T24 cells vras blocked Ijy the broad-spectrum caspase mnlWIor (z-VAD-(mk). Taken together. 1»ie results dearly demonstrate that MDPO etfoclod the arrest ot T24 cells in the GO/Gl phase and induced opoptosis through Intrinsic pathway.
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Relationship between various blochcmlcel, hematological, eomorbid, lifestyle, and denKogrophlc parameters In gallbladder cardnonna: A singlo-centor retrospective study of 342 patients. Raieev Kumar'. R Ravi Knnnan'. Sankar K. Ghosh», Sumit Goyal'.jUagaaisKHonsa? AditI Bhowmlk'. 'Cachar Cancer Hospital & Research Centre. Siichar. Assam, India, 'Assam University, Siichar. Assam. India.
•ncidenoo of gallbladder cancer in rx>rthcastem India ranges (rom AAR 2,3 to 6.9 in males to AAR 4.7 to 14.7 in fomalas. In the single center retnaspectlve study o( 342 gallbladder cancer patients (hat were reported between 2008 and 2010. the relavarKO o( various biochemical, hematological, demographic parameters and dietary and personal habits vrere analyzed. 909* of galltjiodder car>cer patients were diagnosed at stage IV. 80% of patients were reported to hove elevated level ol alkaline phosphatlse and total blllmbln. Hemoglot>ln level v«is (ound elevated In 40»i. 60% vrera reported II on ECOG perfonrtanco status. 85% ot patients wHh gain>ladder carreer were diagnosed at the age ot more than 40 years. TTia peak Incldertce was In the 5th decade. Mala to female ratio was 1:2. 80% of cancers were seen in association with cholelithiasis. 98% o( gallbladder cancers ot>3erved In this study were in Bengali ethnic group. There did not appear to be any religious predilection. 10% o( them have family history of cancer. 70% were tolMcco users, whereas 53% were areca nut users. It was oteerved that 25% of the gallbladder cancer patlerrts were seropositive for hepatitis B Intoctlon. A model (or development o( gallbladder cancer was discussed.-
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Hydroxamic acids aruilogues as Inhibitor of neoplastic human HeLs cells: A self-organizing moloeufar field analysfs (SOMFA) approach. Ram Prakash Ralwade. Jr. National Institute of Technology. Ralpur. Chhattisgarti. India.
Hydroxamic adds have been recognized as compounds of pharmacologteal and toxicologlcal end pathologteal Importance.
Taking the pharmacological pottjntlal of this class ol compound In 0 aooount. a series ol N-arytsutntltuted hydroxamic adds wflh gen«at ^ formula. R1NOH»R2C (•=0). w*ere Rl and R2 are phenyl substituted 'i phenyl gnaops were synthesized.
.;] The antiproliferative aclMty of 18 hydroxamic adds has been j tested in vitro towards human cervix canjinoma. Hela cells by M7T •] assay. The ICj" values were found to l>e In the isnge from 32.38 to , 276.77HM.
Ii^loleaular modeling was performed using Hyperchem Release 7.S software. The stnicture of these compounds v»erB tiutll and opHmbod by molecular mechonlcs MM+ force field and assigned ctiarge by the AMI and Pfvl3 Hamiltonian semierTrperlcal method using MOPAC 2007. The final geometilos arc then performed RMS overlapping to fit with N-p-chlort)phenyl-4-bnamobenzohydroxamk: acid, whlcti has the best antitumor activity Using Vega program ttio final overtayed geometries are converted Into CSSR tile (ormat.
The three dimensional quantitative strucJure-actlvlly relationship (30-OSAR) studies were performed on hydroxamic odds analogues using self organizing molecular field analysis (SOMFA) method wtth their antitumor actlvftles against Hel-a cells.
The tjest 3D-QSAR model obtained with cross-valklatkvi <f (0.779) and cross-validation r* (0.838) show a good predictive ability of potOTKy of hydroxamic acids.
The analysis of SOMFA contour maps provided insight Into the possible modlflcotlon of the molecules for l>etter activity.
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Gene expression profiling of cervical eanoere to delineate progitostic molecutar markers. tetiaJllPtM.5'. Umosh Mahantshetty", Shyam Kishore Shrfvatavo'. Kedar Oeodhar*, Rita Mulherltor'. 'ACTREC, f^avl Mumbal. India, 'Tato Memorial MospHa). Mumbai. India.
Cervical cancer is e major cause Of cancer deaths among wromen in developing countries, accounting for 34% of all women's cancers and Is the most common canoer In Indian women. Clinlcalty localized cervical cancer con be effectlvoty otjiatsd using surgk:3l or radiation treatments. I^ilclastatic disease, however, affecting 15-20% of patients, is essentially Incumbtc. Recent studies have shown ttw use of gene expression profiling by DMA microarroy in the dassffication of various cancers and also in the predictk^n of disease outcome and treatment response. Such a study In cervical cancer moy provide some Insight Into the mechanism o( resistance to troatmom and to predict the trealmenl ouicortw.
To Identify a set ol genes related to disease pttsgnosls o( cervical sciuamous cell carctrx)mas and to estalilish a predictive motliod, protreotment somplcs of F1Q0 stage IIIB of the disease were analyzed using DNA mtoroarroy with Agilent 4"44K chip. The samples were grouped with respect to prognosis of the disease, as having no evidence of disease (NED) after a median follow up of 65 monttis or had disease recunence piS) during the follow up period. Total samples were randomly grouped Into training set (N=33) end test set (N=:6) and all the analysts were done on trtiining set of samples. Raw data ot}taIned were normalized, filtered and analyzed using GenBspring GX11 sofNyaro Gene sets that are ditferentlaily expressed behween the two groups at different p values and (ok) change were selected for dustcrlng and Treoview analysis. Gene sets giving good dusters were sekictad and predlctton models were estatillshed using suppon vector maohinc algorithm. These models vrere then used to predict the prtTgnosis In test set (rr:=8) of samples. The gene set otytalned after analysis could dearly differentfats good and bad prognosis grtjup of eamptes and oouW predict the prognosis of tost samples with 87.5% occurocy. The gene set was further subjected to receiver operator duracterlstlc (ROC) curve analysis to check the Individual predtetlvo capacity of ttie genes. Further analysis of tfw data to mutations in many cancer types. In this study, we analyzed tissue samples of head and neck cancer patients from Barak Valley using PCR and direct sequencing and found three common mutations in nucleotide position 73,263 and 489 with insertions and deletion within the polycytidine stretch in all the individuals so far analyzed. We observed that with the advancement of tumor stage, the number of mutations increases significantly in C-tract. The nucleotides may prove to be the biomarkers for early diagnosis of cancer. Mitochondrial DNA mutations occur in a wide variety of degenerative diseases, sudden infant death, ageing and cancer. Many of the somatic mtDNA mutations in human cancers are located in the displacement loop (D-loop) and particularly at polycytidine stretch (Ctract) referred as D310. Most of the somatic alterations found in tumors showed deletion / insertions of 1-or 2-bp generating D310 variants identical to constitutive polymorphisms. To ensure highest sensitivity in mutation detection and overcome from the polymorphism, we adapted COLD-PCR method followed by DNA sequencing. After analysis of all the sequences for C-Tract alteration, we got some severe changes in the region by means of deletions and insertions. Though the region has polymorphism about 6-9C in first stretches of sequence in D-310 but the sequence of C-Tract has found 30% changes in all cases of head and neck cancerous patient.
Mitochondrial DNA detection at the D-310 region by COLD-PCR in Cancerous tissue
Proc.98th Indian Science Congress, Part II: Abstracts
MATERIALS AND METHODS:
Blood samples are collected from 60 healthy controls and 60 histopathologically confirmed female breast cancer patients (premenopausal and postmenopausal women) aged 25 to 80 years. Serum LDH levels and lipid profile are investigated preoperatively and serum LDH levels are estimated 21 days after the surgery.
RESULT:
There is a significant increase in preoperative and decrease in postoperative serum LDH levels in breast cancer patients as compared to controls. The values of preoperative serum LDH are higher in postmenopausal cases. Breast cancer patients have high BMl with increased total cholesterol, TGL, LDL-C as compared to the controls which is statistically significant.
CONCLUSION:
The findings of this study suggest an immense potential for LDH as a prognostic marker for breast cancer and confirms the association between dyslipidemia, BMI and increased breast cancer risk.
Detection of Mitochondrial Genome Variation in Head and Neck Cancer
Rosy Mondal, Jagadish Hansa, Ravi Kannan and Sankar Kumar Ghosh
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Mitochondrial dysfunction is a halbnark of cancer cells. Mitochondrial DNA (mtDNA) mutations strewn throughout coding and noncoding regions have been reported in cancer. The C-tract region within d-loop is composed of 12-18 cytidine bases that are interrupted by a thymidine base at position 310 and is found to be a "hot spot" region for somatic Schirmer's test, were performed in 40 smokers (80 eyes) and 35 non-smokers (70eyes). Tear film BUT and basal tear secretion was 7.89±2.84sec, 6.38±2.94 mm, in smokers and 9.71±3.23 sec, 10.13±3.96 mm, in nonsmokers respectively (p<0.05).Our results lead us to conclude that quantity and quality of tear film significantly decrease with smoking and this decrease is further related to the amount of smoking. World-wide epidemiological studies have shown that cancer of the uterine cervix is the second most common malignant disease in women. Virtually every cervical cancer (99.7%) is HPV-positive, indicating that the presence of HPV is an obligatory element in the development of cervical cancer. The present study was done by PCR based diagnosis of HPV 16 and HPV 18 infection amongst patients of suspected cervical cancer, confirmed by cytological methods. Twelve women out of a total of fifty studied cases who had positive cervical pap smears (24%) were found to be positive for HPV 16/HPV 18 infection when PCR based technique was applied. The results indicate, perhaps, a greater specificity of PCR based diagnosis or presence of other HPV subtypes as etiological factors in the Southern Assam in which the study group was confined to. be detected and accuratel'' quantified in single tumour sections by use of nanoparticles conjugated to antibodies Nanoparticle-based DNA and RNA delivery systems ofifer several potential advantages for gene delivery to various human tumours, including breast cancer. Supermagnetic nanoparticles have exciting possibilities as contrast agents for cancer detection in vivo, and for monitoring the response to treatment. Several chemotherapy agents are available as nanoparticle formulations, and have at least equivalent efficacy and fewer toxic effects compared with conventional formulations. In the near future, the use of nanotechnology could revolutionise not only oncology, but also the entire discipline of medicine.
Per Based Diagnosis of HPV from Cancer
Patients in the Hospital Based Study from Southern Assam
